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a  b  s  t  r  a  c  t
INTRODUCTION:  Oncocytic  adrenal  neoplasms  are  rare  and  mostly  benign  lesions.  Available  literature
supports  indication  for  a surgical  resection,  but criteria  to predict  aggressive  behavior  are  unreliable,
thus  making  decision  of  surgical  approach  (laparotomy  versus  laparoscopy),  and  extent  of  resection,
difficult  to  define.
PRESENTATION  OF CASE:  This  is  the  case  of a 46-year-old  male,  with  an  incidental  finding  of  a  10  cm
asymptomatic  tumor  in  the  left  adrenal  gland  identified  by MRI,  performed  in the  setting  of  the  ini-
tial  assessment  of  liver  steatosis.  Adrenal  hormone  levels  were  in  the  normal  range,  thus,  a  CT-guided
needle  biopsy  was performed  and  showed  an  adrenocortical  oncocytic  neoplasm.  A  laparoscopic  left
adrenalectomy  was  performed  sparing  the adjacent  left  kidney.  Histological  examination  of  the  resected
tumor  showed  a  10 cm oncocytic  adrenocortical  neoplasm  of  uncertain  malignant  potential  with nega-
tive  resection  margins.  A  follow-up  MRI  was  scheduled  at six  months  after  surgery,  and  no  recurrence
was  found.
CONCLUSIONS:  Although  rare, oncocytic  neoplasms  should  be included  in  the  differential  diagnosis  of
adrenal  “incidentalomas”.  Determination  of their  malignant  potential  is  difficult  in  the  preoperatory
setting.  Final  diagnosis  is  based  on  histological  analysis  of the  whole  surgical  specimen.  Laparoscopic
complete  excision  with  negative  resection  margins  is  feasible  and  safe.










Adrenocortical oncocytic neoplasms (AONs) are rare tumors,
with the most recent systematic review published by Kanitra
in 2018 [1], including 140 cases. In total, there are only 227
cases described in the literature until 2019 [2]. Literature review
is summarized in Table 1. Oncocytic endocrine and neuroen-
docrine tumors can also be discovered in other organs including
thyroid, parathyroid, pituitary gland, lungs and pancreas [3]. Het-
erotopic adrenal tissue with oncocytic transformation has also been
described [4]. Onconcytic tumor synchronous with tumors of other
organs have also been observed (i.e. papillary thyroid cancer) [5].
Abbreviations: AON, adrenocortical oncocytic neoplasm; BMI, body mass
index; CK, cytokeratin; CT, computed tomography; EMA, epithelial membrane
antigen; ESES, European Society of Endocrine Surgeons; 18F-FDG PET-CT, 18F-
fluorodesoxyglucose positron emission tomography; HPF, high-power fields; MRI,
magnetic resonance imaging; PAX8, paired-box gene 8; SUVmax, maximal stan-
dardized uptake value.
∗ Corresponding author at: Department of Visceral Surgery, University Hospi-
tal of Lausanne (CHUV), University of Lausanne (UNIL), Bugnon 46 Road, CH-1011,
Lausanne, Switzerland.













2210-2612/© 2020 The Author(s). Published by Elsevier Ltd on behalf of IJS Publishing Grou
org/licenses/by/4.0/).le  under  the  CC  BY license  (http://creativecommons.org/licenses/by/4.0/).
ONs are more frequent in women and mean age at diagnosis is 47
ears (range 27–72 y.o.) [6]. They are more often localised in left
drenal gland, with a well-defined capsule and a diameter of up to
3 cm (mean = 8 cm)  [2,6,7].
The preoperative evaluation of possible malignancy, the optimal
urgical approach and the extent of resection (potentially including
djacent organs) remain challenging [1].
The work has been reported in line with the SCARE criteria [8].
. Presentation of case
A 46-year-old patient with a non-alcoholic steatohepatitis,
tage F1 fibrosis and overweight (BMI 29.86 kg/m2) had no
ncologic past medical history. He had no relevant family his-
ory of endocrine diseases and was on antidepressant medication
Escitalopram). The initial assessment of the hepatopathy with
bdominal MRI  incidentally revealed a heterogeneous lesion of
he left adrenal gland, measuring 62 × 69 mm,  with a sponta-
eous hyperintense T1 signal (Fig. 1). With a history of blunt
bdominal trauma a few months earlier, an adrenal hematoma was
uspected.
The patient was asymptomatic, without any hormonal abnor-
ality. An abdominal CT-scan was performed three months later,
p Ltd. This is an open access article under the CC BY license (http://creativecommons.
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Table  1
Summary of the literature.












[2] Virarkar et al. 2019 Case report 4 100% Not defined Not defined 6 (3.5–8.5)b
[24] Mills et al. 2019 Retrospective 9 22% 11% 0%/0%/100% 19.8 (4.2–28.5)
[20] Renaudin et al. 2018 Retrospective 43 58% 33% 21%/14%/65% 7.5 (4.5–10.5)
[9] Peynirci et al. 2018 Retrospective 11 55% Not defined 64%/36%/0% 5.8 (2.5–13)
[1] Kanitra et al. 2018 Systematic
review (and
case report)
141 66% 37% 35%/41%/24% 8 (1.6–28.5)




1 100% Conversion Not defined 9.9
[5] Podetta et al. 2017 Case report 1 100% 0% 100%/0%/0% 8.5
[10] Ertan et al. 2017 Retrospective 16 50% Not defined 75%/6%/19% Not defined
[11] Sumner et al. 2017 Case report 1 100% 0% 0%/0%/100% 23
Description of the latest systematic review of the literature and cases not included in its study period.
Ref  = Reference ; Publ = Publication ; Nb = Number ; percent = percentage.
a According to Lin-Weiss-Bisceglia score, 2004.


































tological features and includes the following entities: benign AON,Fig. 1. MRI  showing the large tumor adjacent (in contact) with the left kidney.
which confirmed the left adrenal lesion (67 × 79 × 83 mm)  with a
necrotic center and calcifications, suggesting an adrenal carcinoma.
Multiple left-sided retroperitoneal lymph nodes, up to 13 mm in
size, were also found. The clinical differential diagnosis included
adrenal neoplasm and retroperitoneal sarcoma. The patient under-
went 18F-FDG PET-CT, revealing a hypermetabolic lesion of 67 × 76
× 85 mm,  with a SUVmax of 37. Neither other lesions nor hyper-
metabolic lymph nodes were found (Figs. 2 and 3).
In order to plan the surgical approach and to determine the need
for an en-bloc retroperitoneal resection including the left kidney, a
preoperative biopsy of the lesion was performed that concluded to
AON.
After a multidisciplinary discussion, a laparoscopic left
adrenalectomy (two 12 mm and one 5 mm trocars), with extrac-
tion of the tumor through a subcostal mini-laparotomy protected
by a plastic bag (operative time: 141 min) was performed. Asymp-
tomatic low plasmatic cortisol level was observed at post-operative
day one, and a substitution was prescribed for 3 days. The patient
was discharged home at day 4 after surgery. At two-weeks follow-
up, he reported a slight dyspnoea. A dedicated CT-scan revealed
distal pulmonar embolisms, despite post-operative antithrombotic
prophylaxis. He was successfully treated with anticoagulation.
Pathology examination showed a well delimitated and encap-
sulated 10 cm sized neoplasm weighting 325 g. On section, it
was red-brown with a central haemorrhagic area (Fig. 4A). His-
tologically, the tumor showed a solid and trabecular architecture
and was composed of large cells with abundant eosinophilic cyto-
plasm and centrally located nuclei with prominent nucleoli. Less




306ithout atypical mitotic figures. Neither vascular invasion, sinu-
oidal invasion, nor necrosis were found. Focal capsular infiltration
as observed. Tumor cells were positive for Melan A and nega-
ive for EMA, Cytokeratin (CK) 20, CK7, calretinin, chromogranin,
nhibin, S100, and PAX8. The Ki67 index was 3% (Fig. 4B–D). The
in-Weiss-Bisceglia scoring system only included two minor crite-
ia (size and capsular infiltration) and for this reason the neoplasm
as diagnosed as AON of uncertain malignant potential [12]. The
ultidisciplinary tumor board recommended clinical-radiological
ollow-up with MRI  every 6 months. The first scheduled MRI
evealed no signs of recurrence.
. Discussion
The challenge is to determine the malignant nature or not of
ONs to plan the type of surgical resection. These tumors are rare,
sually benign and large tumors. They mainly occur in middle-aged
omen [13].
AONs are functional in about 17% of cases, and, as for all cases
f adrenal tumors management, hormonal status must be assessed
6].
Radiological findings are unspecific. The available literature sug-
ests that a density of less than 10 HU (lipid-rich) on CT scan,
ithout any necrosis or cyst, is more likely associated with benign
esions but the diagnosis and malignancy cannot be determined
ased on these characteristics [6,14]. Similarly, US, MRI  and 18F-
DG-PET-CT findings can guide, but not confirm, the malignancy
tatus [15].
Available literature on adrenal “incidentalomas” only recom-
end preoperative fine-needle aspiration in selected cases, as it
ay  be associated with some complications (risk 0–12%) and can
ave false negatives. In fact, biopsies should be performed in cases
here surgical attitude could be affected by these results (distinc-
ion between benign and malignant lesions), or in presence of other
nown malignant lesions [1,16,17]. These rare tumors should be
anaged in tertiary reference center for endocrine surgery that
ollow ESES recommendations [17].
The histological hallmark of AON is the presence of oncocytic
ells, which were described in the adrenal glands by Kakimoto et al.
n 1986 [18]. The prognostic classification of AONs is based on his-ON of uncertain malignant potential and malignant AON [2,12].
alignancy is found in about 20% of these tumors and can only be
etermined histologically after surgical resection [6].
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Fig. 3. 18FDG-PET-CT combined with contrast CT-scan showing 
The first classification scheme of adrenocortical neoplasms was
proposed by Weiss [19]. Since the presence of less than 25% clear
cells suggests malignancy, the typical morphology of oncocytic
neoplasms is per se a criterion of malignancy. For this reason, a
revision of this classification was performed by Bisceglia et al. to
produce an ad hoc scheme especially adapted for oncocytic adreno-
cortical tumors (Lin-Weiss-Bisceglia criteria) [12,20]. Major criteria
of malignancy include high mitotic rate (>5 mitoses × 50HPF), the
presence of atypical mitoses and venous invasion. Minor criteria
include large size (>10 cm and/or more than 200 g), the presence of
necrosis, capsular infiltration, and sinusoidal invasion. In presence
of one major criterion, malignancy is confirmed. Moreover, if one
to four minor criteria are present, malignancy potential remains
uncertain. If none of the criteria is present, the lesion is consid-
ered benign [1,6,12]. The immunohistochemical profile can help
for the diagnosis, especially on biopsy material. Markers such as Ki-
67 and topoisomerase have been proposed to help in determining
malignancy [6,7].
In the present case, the malignancy potential could not be
determined after multiple imaging and percutaneous biopsy. We
decided to perform a laparoscopic resection after multidisciplinary
discussion, and final histology concluded to an AON of uncertain
malignant potential. Follow-up did not reveal any recurrence.
Concerning adrenal tumors, international guidelines recom-
mend laparoscopic resection for benign lesions and pheochro-
mocytomas. Many authors have shown interest in analysing
superiority of laparoscopy over open approach for adrenocortical
carcinoma, but literature is still conflicting. At this day, gold stan-





307ortic and epigastric not hypermetabolic enlarged lymph nodes.
e proposed for selected cases in expert centers, depending prin-
ipally on the tumor size (cut-off 10 cm without any adjacent
rgan invasion) [21,22]. Therefore, laparoscopic approach should
e considered for AONs, as it is safely feasible, especially in the
bsence of signs for malignity on assessment by imaging and
istology like in the present case. Resection involves complete
emoval of the lesion, without breaching the tumor capsule and
ith negative resection margins [23]. Panizzo et al. even described
 laparoscopic resection for a twelve centimetres oncocytic carci-
oma, with good oncological results on follow-up at 24 months
7].
There is no consensus regarding the follow-up after resection
nd the necessity for an adjuvant treatment [6]. Oncocytic car-
inomas however seem to have a better prognosis than other
drenocortical carcinomas [20,24]. The latest systematic review of
he literature by Kanitra in 2018 reports a median follow-up of
4 months. Five-year overall survival was  47% for malignant AON,
hereas it was  88% for borderline lesions and 100% for benign
nes. Survival analyses are however limited by the small number
f observations, mostly based on case reports [1].
. Conclusion
AONs are very uncommon tumors with a challenging diagno-
is. Laparoscopic resection with clear margins is safe and feasible
ven in large tumors. There is no consensus in the literature about
ollow-up after resection and each case should be discussed in a
ultidisciplinary tumor board.
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Fig. 4. Macroscopically the tumor was well-circumscribed with a red-brown colou
composed of large cells with abundant eosinophilic cytoplasm (D), positive for mela
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